David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$397M |
| 2 |
YHOO
Yahoo Inc
YHOO
|
+$342M |
| 3 |
Bank of America
BAC
|
+$322M |
| 4 |
Citigroup
C
|
+$260M |
| 5 |
Booking.com
BKNG
|
+$219M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$637M |
| 2 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$397M |
| 3 |
Gilead Sciences
GILD
|
+$358M |
| 4 |
Phillips 66
PSX
|
+$330M |
| 5 |
Apple
AAPL
|
+$320M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.78% |
| 2 | Technology | 11.11% |
| 3 | Financials | 10% |
| 4 | Consumer Discretionary | 8.83% |
| 5 | Communication Services | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
126
PUT
Gilead Sciences
GILD
$181B
| $103M | 0.19% |
1,124,300
-570,700
| -34% | -$51.5M |
|
|
TWTR
127
DELISTED
Twitter, Inc.
TWTR
| $99.3M | 0.18% |
6,000,890
+5,355,376
| +830% | +$93.8M |
|
128
PUT
Microsoft
MSFT
$3.59T
| $98.8M | 0.18% |
1,789,300
-1,727,200
| -49% | -$90.5M |
|
129
Expedia Group
EXPE
$38.6B
| $97.5M | 0.17% |
903,845
-663,570
| -42% | -$70.8M |
|
130
PBF Energy
PBF
$8.72B
| $97.1M | 0.17% |
2,923,431
-230,430
| -7% | -$7.37M |
|
|
MXIM
131
DELISTED
Maxim Integrated Products
MXIM
| $95.9M | 0.17% |
2,608,234
-766,062
| -23% | -$25.7M |
|
|
RAD
132
DELISTED
Rite Aid Corporation
RAD
| $95.3M | 0.17% |
584,956
+267,675
| +84% | +$42.2M |
|
133
IQVIA
IQV
$42.8B
| $95M | 0.17% |
1,459,470
+337,017
| +30% | +$21.3M |
|
134
Gen Digital
GEN
$17.3B
| $94.2M | 0.17% |
5,124,194
-435,256
| -8% | -$8.37M |
|
135
Trane Technologies
TT
$99.8B
| $93.9M | 0.17% |
1,513,794
-905,324
| -37% | -$49.4M |
|
136
T-Mobile US
TMUS
$196B
| $93M | 0.17% |
2,427,550
+1,094,518
| +82% | +$41.3M |
|
137
Bath & Body Works
BBWI
$3.92B
| $92.6M | 0.17% |
1,304,841
+705,464
| +118% | +$50.6M |
|
138
Restaurant Brands International
QSR
$28.2B
| $91.4M | 0.16% |
2,353,975
+235,353
| +11% | +$8.19M |
|
139
Vertex Pharmaceuticals
VRTX
$139B
| $91.1M | 0.16% |
1,146,335
+483,811
| +73% | +$43.8M |
|
140
CALL
AutoZone
AZO
$48.3B
| $90.7M | 0.16% |
113,800
-76,400
| -40% | -$57.8M |
|
|
STJ
141
DELISTED
St Jude Medical
STJ
| $90.4M | 0.16% |
1,643,351
+1,536,052
| +1,432% | +$83.7M |
|
142
RTX Corp
RTX
$283B
| $89.9M | 0.16% |
1,426,345
-887,210
| -38% | -$51.5M |
|
143
Western Digital
WDC
$166B
| $89.2M | 0.16% |
2,499,283
+1,826,871
| +272% | +$65.3M |
|
144
Akamai
AKAM
$15.9B
| $88.7M | 0.16% |
1,595,309
+1,474,881
| +1,225% | +$74.9M |
|
|
IHS
145
DELISTED
IHS INC CL-A COM STK
IHS
| $88.4M | 0.16% |
711,712
+213,294
| +43% | +$22.7M |
|
146
CALL
GE Aerospace
GE
$361B
| $88.2M | 0.16% |
579,037
+60,950
| +12% | +$8.61M |
|
147
CALL
ExxonMobil
XOM
$679B
| $87.1M | 0.16% |
1,041,700
-461,000
| -31% | -$36.9M |
|
|
RTN
148
DELISTED
Raytheon Company
RTN
| $86M | 0.15% |
701,398
+253,681
| +57% | +$31.2M |
|
149
CALL
Netflix
NFLX
$331B
| $85.4M | 0.15% |
8,353,000
-11,609,000
| -58% | -$114M |
|
150
General Motors
GM
$77.2B
| $85.4M | 0.15% |
2,715,738
+365,738
| +16% | +$11M |
|
Similar funds
David Shaw's Q1 2016 Portfolio in Review
As of Q1 2016, David Shaw held 4,137 positions worth $55.7B, down 17% from $67.2B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
David Shaw withdrew a net $9.72B in Q1 2016, closing 773 positions and reducing 1,495 holdings. Its most notable exit was PRECISION CASTPARTS CORP, an estimated $637M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Financials.
Against the trend, David Shaw opened a new position in EQT Corp worth $47.6M.
- David Shaw's largest Q1 2016 buy was EQT Corp: 1,300,361 shares worth $47.6M.
- David Shaw added most to Allergan plc in Q1 2016, an estimated $397M increase.
- David Shaw's biggest Q1 2016 reduction was Gilead Sciences, cutting an estimated $358M.
- David Shaw fully exited PRECISION CASTPARTS CORP in Q1 2016, selling an estimated $637M.
- David Shaw's ten largest holdings make up 9.5% of its $55.7B portfolio in Q1 2016.
- David Shaw opened 382 new positions and closed 773 in Q1 2016.
- David Shaw's portfolio value fell 17% quarter-over-quarter to $55.7B.
Based on D.E. Shaw & Co's 13F filing for Q1 2016, filed 16 May 2016.